AANA 2027 Annual Meeting
May 13-15, 2027
Hollywood, FL
Press Releases
FDA Approves Expanded Clinical Applications for 腦瞳憫��� in Soft Tissue Repair
Label expansion positions 腦瞳憫 for wider adoption in rotator cuff repair. Broader indications reinforce 腦瞳憫 as a versatile alternative to traditional suture anchors for soft tissue-to-bone fixation.
腦瞳憫��� Continues to Simplify Arthroscopic Rotator Cuff Repair Surgery with the Release of 腦瞳憫��� TendoGrip
Successful completion of 50 procedures using its 腦瞳憫��� Rotator Cuff Repair System in the US. A major milestone that signals a shift in soft tissue-to-bone healing approaches. 腦瞳憫 was designed to address the shortcomings of suture-based fixation and represents a completely different approach to rotator cuff repair.
腦瞳憫 Hits 50-Case Milestone with 腦瞳憫���, a Breakthrough in Rotator Cuff Repair
Successful completion of 50 procedures using its 腦瞳憫��� Rotator Cuff Repair System in the US. A major milestone that signals a shift in soft tissue-to-bone healing approaches. 腦瞳憫 was designed to address the shortcomings of suture-based fixation and represents a completely different approach to rotator cuff repair.
腦瞳憫 Announces First Patients Treated with the 腦瞳憫��� Rotator Cuff Repair System in the U.S.
First U.S. patients receive treatment using the revolutionary 腦瞳憫��� Rotator Cuff Repair System. 腦瞳憫 aims to transform the approach to rotator cuff surgery by addressing not just biomechanical fixation, but the critical role of blood flow in tendon-to-bone healing.
腦瞳憫 Announces First Patients Treated with the 腦瞳憫��� Rotator Cuff Repair System
First two patients treated with the 腦瞳憫��� Rotator Cuff Repair System as part of a pre-market clinical study in T羹bingen, Germany.
腦瞳憫��Announces Close of Series A Funding Round
Close of Series A funding raising $4 Million in new equity funding to support the commercial launch of 腦瞳憫簧 in the United States and sponsor a CE mark pre-market clinical study.
腦瞳憫 Receives FDA Clearance of the 腦瞳憫��� Implant System for Rotator Cuff Repair
腦瞳憫 has received clearance from the U.S. Food and Drug Administration (FDA) for 腦瞳憫, a new implant system for the repair of rotator cuff tears.
Medtech Startup 腦瞳憫 Closes 7-digit Seed Financing Round
腦瞳憫 closed a financing round of EUR 1.8 million to fund development of a new surgical technique for shoulder injuries based on a PEEK implant.

